Science and Health News

AstraZeneca, a British-Swedish biopharmaceutical multinational, is interested in new molecules by Russian developers and considering investing more than $16m in an effort to localize production in the Russian Federation, the Skolkovo Foundation website announced, citing a recent statement by AstraZeneca CEO Pascal Soriot.

48% of the Russians put a lot of stock in science and technology development potential; their attitude towards science and technology is about 20% more positive than in the rest of Europe.

Researchers from Russia’s Moscow Lomonosov State University (MSU) and their Swedish colleagues have provided enough evidence to show that denying cancer cells access to nutrient substances could impact therapy both negatively and positively, depending on the type of an anti-tumor drug, portal Indicator.ru reported.

Only 3.2% of the entire output of Russian innovative products were considered novel in the global market in 2015.

Scientists at the research center of the Ulyanovsk State Pedagogical University in the mid-Volga area have developed a material almost identical to the human skin, portal Hi-news.ru reported.

AFK Sistema, a large publicly traded Russian holding company, and Rusnano, this country’s largest state-owned nanotech firm, have announced a joint fund to support high technology projects.

ScreenCardio-NN, an innovative company based in Nizhny Novgorod, in the mid-Volga area, is developing a family of gadgets for noninvasive screening of one’s physiological parameters, including the heart.

UAMS researchers were published today in Trends in Pharmacological Sciences, warning the broader science community and the public about the serious health risks associated with so-called synthetic marijuana products, which are marketed as safe, legal alternatives to marijuana.